Home/ Supplements/ Zinc/ Vialafil 675 mg

Vialafil 675 mg

product on market Capsule NewtonEverett Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Zinc is a well-studied mineral essential for immune function and cellular metabolism. Evidence for the Xanthomonnier Blend is limited due to a lack of clinical data. Overall, the evidence coverage for this specific ingredient profile is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vialafil 675 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
15
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

15 mg (136% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
Xanthomonnier Blend
1350 mg

Other Ingredients

Gelatin Titanium Dioxide FD&C Blue #1 Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, adults take 2 capsules daily preferably with a meal.

Warnings & Precautions

Warning: If you are taking any medications, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of the children.

Do not use if safety seal is broken.

Formulation Notes

(Xanthomnnier) capsules 675 mg per capsule

Men's sexual performance supplement

Non-GMO

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU8 18423 02792 0
DSLD Entry Date2025-05-21
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID330120
Data Updated2026-04-11
Research

Research Evidence

397
Research Sources
55
Avg Quality
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Zinc →
Compare

Similar Products

View all Zinc products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.